PRTN3 and rheumatoid arthritis: Moreover, in a clinical trial conducted on ACPA+-RA patients carrying HLA-DRB1 SE allele's, immunotherapy of autologous dendritic cells loaded with four different citrullinated peptide antigens improved a patient's clinical state.